Frequency of the who metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome

Diabetes and Metabolism

Volumn 28, Issue 5, 2002, Pages 364-376

  Balkau, Beverly ^a   Drivsholm, Thomas ^b   Borch Johnsen, Knut ^c   Wareham, Nick ^d   Yudkin, John S ^e   Morris, Richard ^f   Zavaroni, Ivana ^g   Van Dam, Rob ^h   Feskens, Edith ^h   Gabriel, Rafael ⁱ   Diet, Malmö ^j   Nilsson, Peter ^j   Hedblad, Bo ^j  

^a INSERM   (France)

^b GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^c STENO DIABETES CENTER   (Denmark)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^g UNIVERSITY OF PARMA   (Italy)

^h Natl Inst for Pub Hlth/Environ   (Spain)

ⁱ HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^j LUND UNIVERSITY HOSPITAL   (Sweden)

more..

Author keywords

Cardiovascular disease; Diabetes; Epidemiology; Insulin; Syndrome

Indexed keywords

ADULT; AGE; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; EUROPE; FEMALE; HUMAN; INCIDENCE; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; METHODOLOGY; OBESITY; PATHOPHYSIOLOGY; WORLD HEALTH ORGANIZATION;

EID: 0036861687     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Alberti KGMM, Zimmet PZ for the WHO Consultation. Definition, diagnosis and classification of diabetes mellitus and its complications. Part I, Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med, 1998, 15, 539-553.
2. Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med, 1999, 16, 442-443.
3. WHO consultation. Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Part I, Diagnosis and Classification of Diabetes Mellitus. World Health Organisation, non-communicable disease surveillance. Geneva, 1999.
4. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive Summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) JAMA, 2001, 285, 2486-2497.
5. Drivsholm T, Ibsen H, Schroll M, Davidsen M, Borch-Johnsen K. Increasing prevalence of diabetes mellitus and impaired glucose tolerance among 60-year-old Danes. Diabet Med, 2001, 18, 126-132.
6. Wareham NJ, Ness EM, Byrne CD, Cox BD, Day NE, Hales CN. Cigarette smoking is not associated with hyperinsulinemia, evidence against a causal relationship between smoking and insulin resistance. Metabolism, 1996, 45, 1551-1556.
7. Mohamed-Ali V, Gould MM, Gillies S, Goubet S, Yudkin JS, Haines AP. Association of proinsulin-like molecules with lipids and fibrinogen in non-diabetic subjects - Evidence against a modulating role for insulin. Diabetologia, 1995, 38, 1110-1116.
8. Balkau B, Eschwège E, Tichet J and the D.E.S.I.R. Study Group. Proposed criteria for the diagnosis of diabetes. Evidence from a French epidemiological study (D.E.S.I.R.) Diabetes Metab, 1997, 23, 428-434.
9. Zavaroni I, Bonora E, Pagliara M, Dall'Aglio E, Luchetti L, Buonanno G et a. Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med, 1989, 320, 702-706.
10. Zavaroni I, Bonini L, Gasparini P, Barilli AL, Zuccarelli A, Dall'Aglio E et al. Hyperinsulinemia in a normal population as a predictor of non-insulin-dependent diabetes mellitus, hypertension, and coronary heart disease, the Barilla factory revisited. Metabolism, 1999, 48, 989-994.
11. Lean MEJ, Han TS, Seidell JC. Impairment of health and quality of life in people with large waist circumference. Lancet, 1998, 351, 853-856.
12. Lorenzo C, Serrano-Rios M, Martinez-Larraz MT et al. Was the historic contribution of Spain to the Mexican gene pool partially responsible for the higher prevalence of type 2 diabetes in Mexican-origin populations? The Spanish Insulin Resistance Study Group, the San Antonio Heart Study, and the Mexico City Diabetes Study. Diabetes Care, 2001, 24, 2059-2064.
13. Hedblad B, Nilsson P, Janzon L, Berglund G. Relation between insulin resistance and carotid intima-media thickness and stenosis in non-diabetic subjects. Results from a cross-sectional study in Malmo, Sweden. Diabet Med, 2000, 17, 299-307.
14. Robbins DC, Andersen L, Bowsher R, Chance R, Dinesen B, Frank B et al. Report of the American Diabetes Association's Task Force on standardization of the insulin assay. Diabetes, 1996, 45, 242-256.
15. WHO. Obesity. Preventing and managing the global epidemic. Report of A WHO Consultation on Obesity, Geneva, 3-5 June 1997.
16. Hodge AM, Dowse GK, Zimmet PZ. Microalbuminuria, cardiovascular risk factors, and insulin resistance in two populations with a high risk of type 2 diabetes mellitus. Diabet Med, 1996, 13, 441-449.
17. Zavaroni I, Bonini L, Gasparini P, Zuccarelli A, Dall'Aglio E, Barilli L et al. Dissociation between urinary albumin excretion and variables associated with insulin resistance in a healthy population. J Intern Med, 1996, 240, 151-156.
18. Mykkanen L, Zaccaro DJ, Wagenknecht LE, Robbins DC, Gabriel M, Haffner SM. Microalbuminuria is associated with insulin resistance in nondiabetic subjects, the Insulin Resistance Atherosclerosis Study. Diabetes, 1998, 47, 793-800.
19. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults. Findings from the third National Health and Nutrition Examination Survey. JAMA, 2002, 287, 356-359.